Engineering Injectable Anti‐Inflammatory Hydrogels to Treat Acute Myocardial Infarction
Engineering Injectable Anti‐Inflammatory Hydrogels to Treat Acute Myocardial Infarction
About this item
Full title
Author / Creator
Publisher
Singapore: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Acute myocardial infarction (AMI) poses serious threats to human health. Suppressing long‐term inflammation is a promising strategy to improve cardiac function following AMI. However, the direct injection of anti‐inflammatory drugs after AMI can trigger adverse events due to systemic off‐target effects and bioavailability issues. Injectable hydroge...
Alternative Titles
Full title
Engineering Injectable Anti‐Inflammatory Hydrogels to Treat Acute Myocardial Infarction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d23a520657b74b3583e1e6b362f5e980
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d23a520657b74b3583e1e6b362f5e980
Other Identifiers
ISSN
2699-9307
E-ISSN
2699-9307
DOI
10.1002/anbr.202200008
